GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (WBO:EWLS) » Definitions » Cyclically Adjusted PB Ratio

Edwards Lifesciences (WBO:EWLS) Cyclically Adjusted PB Ratio : 11.81 (As of May. 02, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted PB Ratio?

As of today (2024-05-02), Edwards Lifesciences's current share price is €79.82. Edwards Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €6.76. Edwards Lifesciences's Cyclically Adjusted PB Ratio for today is 11.81.

The historical rank and industry rank for Edwards Lifesciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

WBO:EWLS' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.44   Med: 14.8   Max: 26.56
Current: 11.57

During the past years, Edwards Lifesciences's highest Cyclically Adjusted PB Ratio was 26.56. The lowest was 6.44. And the median was 14.80.

WBO:EWLS's Cyclically Adjusted PB Ratio is ranked worse than
94.35% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 2.125 vs WBO:EWLS: 11.57

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Edwards Lifesciences's adjusted book value per share data for the three months ended in Mar. 2024 was €10.871. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6.76 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Edwards Lifesciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted PB Ratio Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.18 21.83 25.42 12.18 10.75

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.93 14.18 10.02 10.75 13.06

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted PB Ratio falls into.



Edwards Lifesciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Edwards Lifesciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=79.82/6.76
=11.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Edwards Lifesciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.871/129.4194*129.4194
=10.871

Current CPI (Mar. 2024) = 129.4194.

Edwards Lifesciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.216 100.560 2.852
201409 2.472 100.428 3.186
201412 2.748 99.070 3.590
201503 3.172 99.621 4.121
201506 3.164 100.684 4.067
201509 3.339 100.392 4.304
201512 3.556 99.792 4.612
201603 3.248 100.470 4.184
201606 3.447 101.688 4.387
201609 3.741 101.861 4.753
201612 3.911 101.863 4.969
201703 4.063 102.862 5.112
201706 4.131 103.349 5.173
201709 4.180 104.136 5.195
201712 3.971 104.011 4.941
201803 4.164 105.290 5.118
201806 4.316 106.317 5.254
201809 4.592 106.507 5.580
201812 4.430 105.998 5.409
201903 4.880 107.251 5.889
201906 4.967 108.070 5.948
201909 5.538 108.329 6.616
201912 5.952 108.420 7.105
202003 5.699 108.902 6.773
202006 5.486 108.767 6.528
202009 5.739 109.815 6.764
202012 6.023 109.897 7.093
202103 6.293 111.754 7.288
202106 6.838 114.631 7.720
202109 7.546 115.734 8.438
202112 8.276 117.630 9.105
202203 8.541 121.301 9.113
202206 9.072 125.017 9.391
202209 10.139 125.227 10.478
202212 9.011 125.222 9.313
202303 9.214 127.348 9.364
202306 9.680 128.729 9.732
202309 10.285 129.860 10.250
202312 10.145 129.419 10.145
202403 10.871 129.419 10.871

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Edwards Lifesciences  (WBO:EWLS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Edwards Lifesciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (WBO:EWLS) Business Description

Traded in Other Exchanges
Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (WBO:EWLS) Headlines

No Headlines